• BridgeBio Pharma average gross margin for 2023 was 66.54%, a 29.14% increase from 2022.
• BridgeBio Pharma average gross margin for 2022 was 93.91%, a 4.12% decline from 2021.
• BridgeBio Pharma average gross margin for 2021 was 97.95%, a 2.05% decline from 2020.

Gross margin can be defined as a company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage.